Abbott India Ltd. benchmarking: Perfomance to industry peers

Financial

	Abbott India	Glenmark Pharma	Aurobindo Pharma
Operational Metrics
Pharmaceuticals
Domestic Sales Growth - YoY	8.2 %	10.3 %	n/a
R&D as a % of Total Sales	0.02 %	7.3 %	5.0 %
Financials
5 yr Average ROE	30.11 %	3.99 %	12.72 %
5yr average Equity Multiplier	1.43	1.78	1.46
5yr Average Asset Turnover Ratio	1.14	0.8	0.68
5yr Avg Net Profit Margin	18.53 %	2.85 %	12.5 %
Price to Book	14.85	5.79	1.93
P/E	39.47	54.93	19.72
5yr Avg Cash Conversion Cycle	-46.68 Days	-150.94 Days	-46.37 Days
Inventory Days	45.22 Days	32.28 Days	59.62 Days
Days Receivable	19.34 Days	32.34 Days	30.33 Days
Days Payable	109.21 Days	201.14 Days	121.28 Days
5yr Average Interest Coverage Ratio	97.37	4.25	43.54
5yr Avg ROCE	38.77 %	17.54 %	15.27 %
5yr Avg Operating Profit Margin	23.42 %	15.96 %	19.22 %
5 yr average Debt to Equity	0.0	0.38	0.19
5yr CAGR Net Profit	15.41 %	1.54 %	-8.16 %
5yr Average Return on Assets	21.03 %	2.09 %	8.64 %
Shareholdings
Promoter Holding	74.99 %	46.65 %	51.82 %
Share Pledged by Promoters	0.0	0.0	17.5 %
Change in Promoter Holding (3 Yrs)	0.0	0.0	-0.01 %
Change in Mutual Fund Holding (3 Yrs)	2.11 %	10.05 %	10.34 %

Business

	Abbott India	Glenmark Pharma	Aurobindo Pharma
Product Wise Break-Up	Product Wise Break-Up Anti Diabetic 42.82 Gastro Intestinal 25.46 Central Nervous System (CNS) 12.65 Hormones 11.59 Women`s health 7.48 Vitamin, Minerals & Nutrition 0 Hepatoprotectives 0 Respiratory 0 Vaccines 0 cardiovascular system 0 Derma 0 Anti-Infectives 0 Metabolic 0 Pain 0 Glenmark Pharma (Branded generics) 0 Glenmark generics 0 API 0 Formulations 0	Product Wise Break-Up Hepatoprotectives 0 Women`s health 0 Anti Diabetic 0 Branded Generics 60.46 Vitamin, Minerals & Nutrition 0 Anti-Infectives 0 Formulations 0 Respiratory 0 Vaccines 0 Hormones 0 Central Nervous System (CNS) 0 Gastro Intestinal 0 Metabolic 0 cardiovascular system 0 API 0 Derma 0 Pain 0 Formulations 39.54	Product Wise Break-Up Hepatoprotectives 0 Women`s health 0 Anti Diabetic 0 Glenmark Pharma (Branded generics) 0 Vitamin, Minerals & Nutrition 0 Anti-Infectives 0 Formulations 88.36 Respiratory 0 Vaccines 0 Hormones 0 Central Nervous System (CNS) 0 Gastro Intestinal 0 Metabolic 0 cardiovascular system 0 Active Pharmaceutical Ingredient (API) 11.64 Derma 0 Pain 0 Glenmark generics 0
Location Wise Break-Up	Location Wise Break-Up India 98.81 Rest of the World 1.19 Europe 0 Latin America 0 North America 0 USA 0	Location Wise Break-Up Europe 12.36 North America 73.99 Rest of the World 10.91 USA 0 India 2.73 Latin America 0 Others 0.01	Location Wise Break-Up Europe 29.7 North America 0 Rest of the World 17.0 USA 44.3 India 9.0 Latin America 0
Acute vs Chronic	Acute vs Chronic Chronic 46.0 Acute 27.0 Sub-chronic 27.0	-	-
Dosage Form Break-Up	Dosage Form Break-Up Injectable 39.89 Tablet 39.17 Liquids 15.9 Capsule 3.47 Ointment 0.27 Granules 0.23 Powder 0.19 Others 0.88	-	-
Brand Wise Break-Up	Brand Wise Break-Up Mixtard 19.93 Thyronorm 14.04 Ryzodeg 11.83 Udiliv 11.03 Novomix 9.31 Duphaston 8.88 Duphalac 6.69 Vertin 6.67 Novo Rapid 5.92 Cremaffin Plus 5.69 Claribid 0 Cremaffin 0 Similac 0 Ensure 0 Others 0.01	-	-

Abbott India Ltd.

Abbott India Ltd.

Financial

Business

SIGN UP FOR FREE